Decreased expression of Freud-1/CC2D1A, a transcriptional repressor of the 5-HT1A receptor, in the prefrontal cortex of subjects with major depression

International Journal of Neuropsychopharmacology

Volumn 13, Issue 8, 2010, Pages 1089-1101

  Szewczyk, Bernadeta ^a,e   Albert, Paul R ^b   Rogaeva, Anastasia ^b   Fitzgibbon, Heidi ^a   May, Warren L ^c   Rajkowska, Grazyna ^a   Miguel Hidalgo, Jose J ^a   Stockmeier, Craig A ^a,d   Woolverton, William L ^a   Kyle, Patrick B ^a   Wang, Zhixia ^a   Austin, Mark C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT1A receptors; Major depression; prefrontal cortex; serotonin; transcription factor

Indexed keywords

FLUOXETINE; SEROTONIN 1A RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CC2D1A; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GLIA; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SEX DIFFERENCE;

EID: 77957240708     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000301     Document Type: Article

References (45)

1. Albert PR, Lemonde S (2004). 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10, 575-593. (Pubitemid 39546399)
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995). Localized alterations in pre and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research 688,121-133.
4. Arranz B, Eriksson A, Mellerup E, Plenge P, et al. (1994). Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biological Psychiatry 35, 457-463. (Pubitemid 2091331)
5. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, et al. (2004). Persistent reduction in brain serotonin 1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular Psychiatry 9, 386-392. (Pubitemid 38534699)
6. Cotter D, Mackay D, Chana G, Beasley C, et al. (2002). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12, 386-394. (Pubitemid 34226063)
7. Czesak M, Lemonde S, Peterson EA, Rogaeva A, et al. (2006). Cell-specific repressor or enhancer activities of deaf-1 at a serotonin 1A receptor gene polymorphism. Journal of Neuroscience 26, 1864-1871. (Pubitemid 43236999)
8. Dillon KA, Gross-Isseroff R, Israeli M, Biegon A (1991). Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Research 554, 56-64.
9. Doherty MD, Pickel VM (2001). Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain. Journal of Comparative Neurology 433, 390-400.
10. Drevets WC, Frank E, Price JC, Kupfer DJ, et al. (1999). PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46, 1375-1387.
11. Drevets WC, Frank E, Price JC, Kupfer DJ, et al. (2000). Serotonin type-1A receptor imaging in depression. Nuclear Medicine and Biology 27, 499-507. (Pubitemid 30658154)
12. Drevets WC, Thase ME, Moses-Kolko EL, Price J, et al. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 34, 865-877. (Pubitemid 47505401)
13. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (version 2). Biometrics Research Department, New York State Psychiatric Institute.
14. Hensler JG (2002). Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26, 565-573.
15. Hensler JG, Kovachich GB, Frazer A (1991). A quantitative autoradiographic study of serotonin1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4, 131-144.
16. Hirvonen J, Karlsson H, Kajander J, Lepola A, et al. (2008). Decreased brain serotonin 5-HT1A receptor availability in medication naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. International Journal of Neuropsychopharmacology 11, 465-476. (Pubitemid 351744802)
17. Hsiung SC, Adlersberg M, Arango V, Mann JJ, et al. (2003). Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, akt and mitogen-activated protein kinase. Journal of Neurochemistry 87, 182-194. (Pubitemid 37210652)
18. Iyo AH, Kieran N, Chandran A, Lenicov FR, et al. (2009). Differential regulation of the serotonin 1A transcriptional modulators five prime repressor element under dual repression-1 and nuclear-deformed epidermal autoregulatory factor by chronic stress. Neuroscience 163, 1119-1127.
19. Lemonde S, Turecki G, Bakish D, Du L, et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. Journal of Neuroscience 23, 8788-8799. (Pubitemid 37176660)
20. Le Poul E, Boni C, Hanoun N, Laporte AM, et al. (2000). Differential adaption of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39,110-122.
21. Little RC, Milleken GA, Stroup WW, Wolfinger RD (1996). SAS System for Mixed Models. Cary, NC: SAS Institute Inc.
22. Lopez-Figueroa L, Norton CS, Lopez-Figueroa MO, Rmellini-Dodel D, et al. (2004). Serotonin 5-HT1A, 5-HT1B and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biology Psychiatry 55, 225-233.
23. Lowther S, De Paermentier F, Cheetham SC, Crompton MR, et al. (1997). 5-HT1A receptor binding sites in postmortem brain samples from depressed suicides and controls. Journal of Affective Disorders 42, 199-207. (Pubitemid 27170165)
24. Matsubara S, Arora RC, Meltzer HY (1991). Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. Journal of Neural Transmission: General Section 85, 181-194.
25. Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser J, et al. (2000). GFAP immunoreactivity in the dorsolateral prefrontal cortex separates young from old adults with major depressive disorder. Biological Psychiatry 48, 860-872.
26. Moses-Kolko EL, Wisner KL, Price JC, Berga SL, et al. (2008). Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertility and Sterility 89, 685-692.
27. Ou XM, Lemonde S, Jafar-Nejad H, Bown CD, et al. (2003). Freud-1: a neuronal calcium-regulated repressor of the 5-HT1A receptor gene. Journal of Neuroscience 23, 7415-7425. (Pubitemid 36999534)
28. Patel TD, Zhou FC (2005). Ontogeny of 5-HT1A receptor expression in the developing hippocampus. Developmental Brain Research 157, 42-57. (Pubitemid 40812943)
29. Rajkowska G (2002). Cell pathology in mood disorders. Seminars in Clinical Neuropsychiatry 7, 281-292.
30. Rajkowska G, Goldman-Rakic PS (1995). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cerebral Cortex 5, 307-322.
31. Rajkowska G, Miguel-Hidalgo JJ (2007). Gliogenesis and glial pathology in depression. CNS Neurological Disorders Drug Targets 6, 219-233. (Pubitemid 46916253)
32. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, et al. (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biological Psychiatry 58, 297-306. (Pubitemid 41133623)
33. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45,1085-1098. (Pubitemid 29236550)
34. Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, et al. (2007). Reduction in calbindin-immunoreactive GABA interneurons in the prefrontal cortex in major depression. Neuropsychopharmacology 32, 471-482. (Pubitemid 46106953)
35. Rogaeva A, Albert PR (2007). The mental retardation gene CC2D1A/Freud-1 encodes a long isoform that binds conserved DNA elements to repress gene transcription. European Journal of Neuroscience 26, 965-974. (Pubitemid 47274621)
36. Rogaeva A, Ou XM, Jafar-Nejad H, Lemonde S, et al. (2007). Differential repression by Freud-1/CC2D1A at a polymorphic site in the dopamine-D2 receptor gene. Journal of Biological Chemistry 282, 20897-20905. (Pubitemid 47099904)
37. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, et al. (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57, 174-180.
38. Savitz J, Lucki I, Drevets WC (2009). 5-HT1A receptor function in major depressive disorder. Progress in Neurobiology 88, 17-31.
39. Si X, Miguel-Hidalgo JJ, O'Dwyer G, Stockmeier CA, et al. (2004). Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 29, 2088-2096. (Pubitemid 39486561)
40. Spitzer RL, Endiott J (1978). Schedule for Affective Disorders and Schizophrenia (SADS), 3rd edn. New York: New York State Psychiatric Institute.
41. Stockmeier CA (2003). Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. Journal of Psychiatric Research 37, 357-373.
42. Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, et al. (1997). Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16, 162-173. (Pubitemid 27086431)
43. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, et al. (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry 56, 640-650. (Pubitemid 39446845)
44. Stockmeier CA, Howley E, Shi X, Sobanska A, et al. (2009). Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. Journal of Psychiatric Research 43, 887-894.
45. Szewczyk B, Albert PR, Burns AM, Czesak M, et al. (2009). Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. International Journal of Neuropsychopharmacology 12, 155-168.